Covered recipient · General Payments record
RAYNA SOPHIE TARLOW
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2023
$820.28
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $533.78 | 26 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $249.15 | 12 |
| Axsome Therapeutics, Inc. | $93.84 | 4 |
| PFIZER INC. | $45.29 | 2 |
| Exact Sciences Corporation | $43.83 | 2 |
| Tris Pharma Inc | $33.41 | 2 |
| Novo Nordisk AS | $18.56 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.95 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $16.06 | 1 |
| SHIELD THERAPEUTICS INC | $15.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2023 2022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.05 | 01/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009986763 | CMS |
| ABBVIE INC. | $15.33 | 01/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009986767 | CMS |
| ABBVIE INC. | $31.87 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009986773 | CMS |
| ABBVIE INC. | $24.27 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009986775 | CMS |
| ABBVIE INC. | $15.86 | 02/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009986779 | CMS |
| ABBVIE INC. | $22.07 | 02/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009986784 | CMS |
| ABBVIE INC. | $25.92 | 03/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009986787 | CMS |
| ABBVIE INC. | $14.91 | 06/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009986792 | CMS |
| ABBVIE INC. | $27.25 | 06/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009986795 | CMS |
| ABBVIE INC. | $12.37 | 07/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009986799 | CMS |
| ABBVIE INC. | $24.68 | 07/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009986804 | CMS |
| ABBVIE INC. | $12.57 | 09/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009986807 | CMS |
| Axsome Therapeutics, Inc. | $23.66 | 01/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056384353 | CMS |
| Axsome Therapeutics, Inc. | $23.38 | 03/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056384355 | CMS |
| Axsome Therapeutics, Inc. | $26.75 | 04/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056384357 | CMS |
| Axsome Therapeutics, Inc. | $20.05 | 11/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056384359 | CMS |
| Exact Sciences Corporation | $22.04 | 01/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026847345 | CMS |
| Exact Sciences Corporation | $21.79 | 06/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026847425 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $16.06 | 02/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034176553 | CMS |
| Novo Nordisk Inc | $18.56 | 05/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002796785 | CMS |
| PFIZER INC. | $16.06 | 06/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049844765 | CMS |
| PFIZER INC. | $29.23 | 10/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050068993 | CMS |
| Shield Therapeutics Inc | $15.69 | 06/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1045772107 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.95 | 04/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056028921 | CMS |
| Tris Pharma Inc | $15.64 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059346101 | CMS |
| Tris Pharma Inc | $17.77 | 12/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059346343 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.